Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy, Hepatic Insufficiency”

57 trials

Showing 20 of 57 results

Early research (Phase 1)Not Yet RecruitingNCT07055412
What this trial is testing

Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects

Who this might be right for
Pharmacokinetic DifferencesY-3Saftey+3 more
Neurodawn Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Early research (Phase 1)Study completedNCT00859053
What this trial is testing

Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment

Who this might be right for
Hepatic Insufficiency
Bristol-Myers Squibb 46
Not applicableStudy completedNCT05958420
What this trial is testing

Evaluation of HDL Subfraction Changes and HDL-Associated Enzymes in Liver Failure Patients and Healthy Donors

Who this might be right for
Liver Failure
Akdeniz University 40
Early research (Phase 1)Looking for participantsNCT07165002
What this trial is testing

The Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 32
Early research (Phase 1)Study completedNCT05112419
What this trial is testing

Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal Impairment

Who this might be right for
Hepatic ImpairmentRenal Impairment
AstraZeneca 12
Early research (Phase 1)Study completedNCT03962049
What this trial is testing

Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

Who this might be right for
Hepatic ImpairmentHealthy Participants
ObsEva SA 24
Early research (Phase 1)Study completedNCT00416702
What this trial is testing

Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function

Who this might be right for
Hepatic Insufficiency
Novartis 32
Early research (Phase 1)Study completedNCT05440344
What this trial is testing

Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

Who this might be right for
Hepatic InsufficiencyHealthy
Eli Lilly and Company 27
Early research (Phase 1)Study completedNCT06719128
What this trial is testing

Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants

Who this might be right for
Hepatic InsufficiencyHealthy
Eli Lilly and Company 46
Post-approval studies (Phase 4)Study completedNCT01846455
What this trial is testing

Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

Who this might be right for
Hepatic FailureHepatic ImpairmentChronic Hepatitis C Infection With Hepatic Coma
Indivior Inc. 43
Early research (Phase 1)Study completedNCT06911320
What this trial is testing

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Who this might be right for
Healthy Volunteer StudyHepatic ImpairmentRenal Impairment
Atea Pharmaceuticals, Inc. 28
Not applicableStudy completedNCT02124382
What this trial is testing

Living Donor Liver Transplantation in Children

Who this might be right for
Pediatric Liver Transplanted RecipientsHealthy Donors
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 500
Early research (Phase 1)Study completedNCT03968848
What this trial is testing

Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite

Who this might be right for
Hepatic ImpairmentHepatic InsufficiencyHealthy Subjects
Acerta Pharma BV 16
Early research (Phase 1)Study completedNCT01043887
What this trial is testing

Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)

Who this might be right for
Healthy VolunteersHepatic Insufficiency
Merck Sharp & Dohme LLC 19
Early research (Phase 1)Study completedNCT04867941
What this trial is testing

Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196

Who this might be right for
Hepatic Insufficiency
Acerta Pharma BV 18
Early research (Phase 1)Study completedNCT02191865
What this trial is testing

Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 33
Early research (Phase 1)Study completedNCT02334800
What this trial is testing

Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib

Who this might be right for
Healthy, Hepatic Insufficiency
Pfizer 28
Post-approval studies (Phase 4)Study completedNCT01767103
What this trial is testing

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers

Who this might be right for
Hepatic Impairment
ApoPharma 21
Early research (Phase 1)Study completedNCT06190691
What this trial is testing

Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation